An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens
Clicks: 265
ID: 269778
2016
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
The use of interferon- and RBV-free regimens for HCV is associated with better patients' experience and work productivity during treatment.| Reference Key |
zm2016thean
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Younossi ZM;Stepanova M;Henry L;Nader F;Hunt S;; |
| Journal | the american journal of gastroenterology |
| Year | 2016 |
| DOI | DOI not found |
| URL | |
| Keywords |
hepatitis c
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
female
male
middle aged
Clinical Trial
Phase III
Multicenter Study
Retrospective Studies
drug therapy
combination
antiviral agents / therapeutic use*
ribavirin / therapeutic use
chronic / drug therapy*
sofosbuvir / therapeutic use
maria stepanova
zobair m younossi
interferons / therapeutic use
patient reported outcome measures*
pmid:27021197
doi:10.1038/ajg.2016.99
sharon hunt
benzimidazoles / therapeutic use
fluorenes / therapeutic use
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.